The deleterious impact of a non-synonymous SNP on protein structure and function is apparent in hypertension
- PMID: 34961886
- DOI: 10.1007/s00894-021-04997-6
The deleterious impact of a non-synonymous SNP on protein structure and function is apparent in hypertension
Abstract
Essential hypertension (EH) is a significant health issue around the globe. The indifferent therapy regimen suggests varied physiological functions due to the lifestyle and genetic presentations of an individual. The endothelial nitric oxide synthase (NOS3) gene is a crucial vascular system marker in EH that contributes significantly to the phenotype. Hence, the present study aimed to employ the candidate gene approach and investigate the association between NOS3 single nucleotide polymorphism (SNP) E298D (G894T/rs1799983) by applying several in silico tools and validation through human samples screening. We corroborated computational findings through a case-control study comprising 294 controls and 299 patients; the 894T allele emerged significantly as the risk allele (odds ratio=2.07; P=6.38E-05). The in silico analyses highlighted the significance of E298D on the native structure and function of NOS3. The dynamics simulation study revealed that the variant type 298D caused structural destabilization of the protein to alter its function. Plasma nitrite levels were reduced in patients (P=0.0002), and the same correlated with the 894T allele. Furthermore, correlations were apparent between clinical, genotype, and routine biochemical parameters. To conclude, the study demonstrated a perceptible association between the SNP E298D and NOS3 protein structure stability that appears to have a bearing on the enzyme's function with a deleterious role in EH.
Keywords: Essential hypertension; Genotyping; Missense SNP; Molecular docking simulations; NOS3.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Carretero OA, Oparil S (2000) Essential hypertension. Part I: Definition and etiology. Circulation 101:329–335. https://doi.org/10.1161/01.cir.101.3.329 - DOI - PubMed
-
- Chobanian AV (2001) Control of hypertension: an important national priority. N Engl J Med 345:534–535. https://doi.org/10.1056/NEJM200108163450709 - DOI - PubMed
-
- Kearney PM, Whelton M, Reynolds K (2005) Global burden of hypertension: analysis of worldwide data. Lancet 365:217–223. https://doi.org/10.1016/S0140-673605.17741-1 - DOI - PubMed
-
- Benjamin EJ, Blaha MJ, Chiuve SE (2007) Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation 135:e646. https://doi.org/10.1161/CIR.0000000000000485 - DOI
-
- Arnett DK, Claas SA, Glasser SP (2006) Pharmacogenetics of antihypertensive treatment. Vasc Pharmacol 44:107–118. https://doi.org/10.1016/j.vph.2005.09.010 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
